Total Payments
$69,352
2024 Payments
$3,668
Companies
13
Transactions
61
Medicare Patients
574
Medicare Billing
$40,624
Payment Breakdown by Category
Consulting$62,257 (89.8%)
Travel$3,805 (5.5%)
Other$2,000 (2.9%)
Food & Beverage$1,273 (1.8%)
Education$17.41 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $62,257 | 19 | 89.8% |
| Travel and Lodging | $3,805 | 16 | 5.5% |
| Honoraria | $2,000 | 1 | 2.9% |
| Food and Beverage | $1,273 | 24 | 1.8% |
| Education | $17.41 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shionogi Inc | $30,000 | 2 | $0 (2017) |
| Medicines360 | $13,518 | 12 | $0 (2018) |
| AMAG Pharmaceuticals, Inc. | $7,280 | 21 | $0 (2018) |
| PFIZER INC. | $4,500 | 3 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $4,243 | 10 | $0 (2017) |
| Sebela Pharmaceuticals Inc. | $3,000 | 2 | $0 (2018) |
| Sumitomo Pharma America, Inc. | $3,000 | 3 | $0 (2024) |
| Myovant Sciences Inc. | $2,000 | 2 | $0 (2022) |
| Mylan Inc. | $1,653 | 1 | $0 (2024) |
| Duchesnay USA Incorporated | $108.18 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,668 | 4 | Sumitomo Pharma America, Inc. ($2,000) |
| 2023 | $1,000 | 1 | Sumitomo Pharma America, Inc. ($1,000) |
| 2022 | $2,000 | 2 | Myovant Sciences Inc. ($2,000) |
| 2021 | $17.41 | 1 | PFIZER INC. ($17.41) |
| 2019 | $4,345 | 1 | PFIZER INC. ($4,345) |
| 2018 | $18,602 | 21 | Medicines360 ($13,518) |
| 2017 | $39,719 | 31 | Shionogi Inc ($30,000) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Endocrinology | ||||||
| 09/09/2024 | Mylan Inc. | XULANE (Drug) | Consulting Fee | Cash or cash equivalent | $1,653.00 | General |
| Category: Contraceptives, Transdermal | ||||||
| 06/13/2024 | Sumitomo Pharma America, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 04/04/2024 | Sumitomo Pharma America, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 05/03/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: HORMONE THERAPY | ||||||
| 10/05/2022 | Myovant Sciences Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 07/13/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: HORMONE THERAPY | ||||||
| 06/30/2021 | PFIZER INC. | MYFEMBREE (Drug) | Education | In-kind items and services | $17.41 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 03/15/2019 | PFIZER INC. | DEPO-PROVERA (Drug) | Consulting Fee | Cash or cash equivalent | $4,345.00 | General |
| Category: GENITOURINARY (SEXUAL HEALTH) | ||||||
| 11/02/2018 | Medicines360 | Liletta (Device) | Travel and Lodging | Cash or cash equivalent | $170.00 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 10/12/2018 | Duchesnay USA Incorporated | Osphena (Drug) | Food and Beverage | In-kind items and services | $91.83 | General |
| Category: Women's Health | ||||||
| 09/22/2018 | Medicines360 | Liletta (Device) | Travel and Lodging | Cash or cash equivalent | $415.60 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 09/22/2018 | Medicines360 | Liletta (Device) | Travel and Lodging | Cash or cash equivalent | $224.87 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 09/22/2018 | Medicines360 | Liletta (Device) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 09/22/2018 | Medicines360 | Liletta (Device) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 09/22/2018 | Medicines360 | Liletta (Device) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 09/22/2018 | Medicines360 | Liletta (Device) | Consulting Fee | Cash or cash equivalent | $25.00 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 09/21/2018 | Medicines360 | Liletta (Device) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 06/02/2018 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug), INTRAROSA | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 06/02/2018 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug), INTRAROSA | Travel and Lodging | In-kind items and services | $320.29 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 06/02/2018 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug), INTRAROSA | Travel and Lodging | In-kind items and services | $273.40 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 06/02/2018 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $153.18 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 06/02/2018 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug), INTRAROSA | Travel and Lodging | Cash or cash equivalent | $142.20 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 06/02/2018 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $85.00 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 06/02/2018 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug), INTRAROSA | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 105 | 111 | $23,057 | $7,351 |
| 2022 | 4 | 149 | 157 | $32,798 | $10,234 |
| 2021 | 4 | 140 | 153 | $36,813 | $11,475 |
| 2020 | 4 | 180 | 199 | $44,620 | $11,565 |
Total Patients
574
Total Services
620
Medicare Billing
$40,624
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 25 | 27 | $9,450 | $2,241 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 34 | $5,712 | $2,050 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 19 | $4,826 | $1,835 | 38.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 31 | 31 | $3,069 | $1,225 | 39.9% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 45 | 50 | $17,500 | $4,120 | 23.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 60 | 60 | $5,940 | $2,421 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 30 | $5,040 | $2,048 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 17 | $4,318 | $1,645 | 38.1% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 60 | 64 | $22,400 | $5,794 | 25.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 43 | $7,224 | $2,915 | 40.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 17 | $4,318 | $1,609 | 37.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 29 | 29 | $2,871 | $1,157 | 40.3% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 61 | 71 | $24,850 | $5,845 | 23.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 57 | 65 | $10,920 | $3,274 | 30.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 50 | 50 | $4,950 | $2,055 | 41.5% |
| 76857 | Ultrasound of pelvis | Office | 2020 | 12 | 13 | $3,900 | $390.74 | 10.0% |
About Dr. Andrew Kaunitz, M.D
Dr. Andrew Kaunitz, M.D is a Obstetrics & Gynecology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093781635.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Kaunitz, M.D has received a total of $69,352 in payments from pharmaceutical and medical device companies, with $3,668 received in 2024. These payments were reported across 61 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($62,257).
As a Medicare-enrolled provider, Kaunitz has provided services to 574 Medicare beneficiaries, totaling 620 services with total Medicare billing of $40,624. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Jacksonville, FL
- Active Since 02/24/2006
- Last Updated 09/03/2007
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1093781635
Products in Payments
- Osphena (Drug) $30,108
- Liletta (Device) $13,518
- DEPO-PROVERA (Drug) $4,345
- INTRAROSA (Drug) $4,288
- MAKENA (Drug) $2,992
- MYFEMBREE (Drug) $2,017
- XULANE (Drug) $1,653
- BRISDELLE (Drug) $1,000
- IMPLANON (Drug) $838.70
- DUAVEE (Drug) $137.50
- Mirena (Drug) $18.60
- Paragard T 380A (Drug) $14.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Jacksonville
Dr. David Miller, M.d, M.D
Obstetrics & Gynecology — Payments: $26,615
Obstetrics & Gynecology $26,615
Jason Thompson, Md, MD
Obstetrics & Gynecology — Payments: $11,245
Obstetrics & Gynecology $11,245
Dr. Jason Patzwald, Do, DO
Obstetrics & Gynecology — Payments: $10,530
Obstetrics & Gynecology $10,530
Martin Garcia, M.d, M.D
Obstetrics & Gynecology — Payments: $8,060
Obstetrics & Gynecology $8,060
Dr. Marta Perez, Md, MD
Obstetrics & Gynecology — Payments: $7,925
Obstetrics & Gynecology $7,925
Dr. Deirdre Lahey, D.o, D.O
Obstetrics & Gynecology — Payments: $7,603
Obstetrics & Gynecology $7,603